Every day your therapy sits in the development pipeline costs you money and costs patients the opportunity for treatment. At Cardinal Health, we know how critical it is to get it right the first time at every step of the development process for your pharmaceutical, biotechnology and medical device products. We’ll partner with you to devise the best pathway for your therapy from inspiration to marketing product approval and beyond.
For four decades, our industry-trained regulatory consultants
have provided expertise and guidance to help pharmaceutical, biotechnology and medical device companies get their products to market quickly. Our regulatory and product development strategies are designed to reduce the risk of failure and increase financial returns on your research investments. We provide efficient scientific and regulatory consulting services throughout the full product lifecycle to help ensure the continued success of your product post-approval.
Each one of our 150+ scientific and regulatory consultants
has an average of more than 15 years of industry and FDA experience and training. Our regulatory experts
have had successful interactions with global regulatory agencies and have worked with every review division of the FDA. Cardinal Health has provided support for more than 100 New Drug Application (NDA), Biologic License Application (BLA) and Abbreviated New Drug Application (ANDA) approvals and has provided drug development services for new drugs in all major therapeutic areas. We leverage the extensive knowledge and expertise gained from our experiences with global clients to continue improving upon our services and internal processes.